SBFM Q4 2021 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$85,118+203.9% YoY

Gross Profit

$23,82928.0% margin

Operating Income

-$280,000-329.0% margin

Net Income

$667,116783.8% margin

EPS (Diluted)

$0.65

QoQ Revenue Growth

+69.0%

Cash Flow

Operating Cash Flow

-$312,113

Free Cash Flow

-$312,113

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2M

Total Liabilities

$2M

Stockholders' Equity

$211,662

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85,118	$28,013	+203.9%
Gross Profit	$23,829	$17,550	+35.8%
Operating Income	-$280,000	-$343,000	+18.4%
Net Income	$667,116	-$1M	+161.5%